Table: Santen Pharm -2020/21 parent results

SANTEN PHARMACEUTICAL

11/05/2021 07:00

May 11 (Reuters)- 
          Santen Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2021    Mar 31, 2020   Mar 31, 2022     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            186.11          182.61                                
                 (+1.9 pct)      (+3.6 pct)                              
  Operating         23.61           34.43                                
                 (-31.4 pct)     (+4.8 pct)                              
  Recurring         25.32           34.86                                
                 (-27.4 pct)     (+5.0 pct)                              
  Net               21.75           27.40                                
                 (-20.6 pct)     (-2.2 pct)                              
  EPS             54.44 yen       68.63 yen                              
  EPS Diluted     54.33 yen       68.46 yen                              
  Ann Div         28.00 yen       27.00 yen      32.00 yen               
  -Q2 Div         14.00 yen       13.00 yen      16.00 yen               
  -Q4 Div         14.00 yen       14.00 yen      16.00 yen               
  
  NOTE - Santen Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4536.T